Literature DB >> 18046542

A novel mechanism of mechanical stress-induced angiotensin II type 1-receptor activation without the involvement of angiotensin II.

Noritaka Yasuda1, Hiroshi Akazawa, Yingjie Qin, Yunzeng Zou, Issei Komuro.   

Abstract

The angiotensin II (AngII) type 1 (AT1) receptor is a seven transmembrane-spanning G-protein-coupled receptor, and the activation of AT1 receptor plays an important role in the development of load-induced cardiac hypertrophy. Locally generated AngII was believed to trigger cardiac hypertrophy by an autocrine or paracrine mechanism. However, we found that mechanical stress can activate AT1 receptor independently of AngII. Without the involvement of AngII, mechanical stress not only activates extracellular signal-regulated kinases in vitro, but also induces cardiac hypertrophy in vivo. All of these events are inhibited by candesartan as an inverse agonist for AT1 receptor. It is conceptually novel that AT1 receptor directly mediates mechanical stress-induced cellular responses, and inverse-agonist activity emerges as an important pharmacological parameter for AT1-receptor blockers that determines their efficacy in preventing organ damage in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046542     DOI: 10.1007/s00210-007-0215-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

1.  TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor.

Authors:  Shin-ichiro Miura; Jingli Zhang; John Boros; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

Review 2.  Activation of G-protein-coupled receptors: a common molecular mechanism.

Authors:  Sadashiva S Karnik; Camelia Gogonea; Supriya Patil; Yasser Saad; Takanobu Takezako
Journal:  Trends Endocrinol Metab       Date:  2003-11       Impact factor: 12.015

Review 3.  Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.

Authors:  Richard A Bond; Ad P Ijzerman
Journal:  Trends Pharmacol Sci       Date:  2006-01-06       Impact factor: 14.819

4.  Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.

Authors:  K Harada; I Komuro; I Shiojima; D Hayashi; S Kudoh; T Mizuno; K Kijima; H Matsubara; T Sugaya; K Murakami; Y Yazaki
Journal:  Circulation       Date:  1998-05-19       Impact factor: 29.690

5.  Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; Y Hiroi; T Mizuno; K Maemura; H Kurihara; R Aikawa; H Takano; Y Yazaki
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

6.  Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure.

Authors:  Donald E White; Pierre Coutu; Yan-Fen Shi; Jean-Claude Tardif; Stanley Nattel; René St Arnaud; Shoukat Dedhar; William J Muller
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

7.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor.

Authors:  S Miura; Y H Feng; A Husain; S S Karnik
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

9.  Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; T Mizuno; H Takano; Y Hiroi; K Ueki; K Tobe
Journal:  Circ Res       Date:  1995-08       Impact factor: 17.367

10.  Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.

Authors:  Stéphane S Martin; Brian J Holleran; Emanuel Escher; Gaétan Guillemette; Richard Leduc
Journal:  Mol Pharmacol       Date:  2007-04-19       Impact factor: 4.436

View more
  20 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  Cardiovascular Adaptations Induced by Resistance Training in Animal Models.

Authors:  S F S Melo; N D da Silva Júnior; V G Barauna; E M Oliveira
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

3.  The role of mechanical tension on lipid raft dependent PDGF-induced TRPC6 activation.

Authors:  Lei Lei; Shaoying Lu; Yi Wang; Taejin Kim; Dolly Mehta; Yingxiao Wang
Journal:  Biomaterials       Date:  2014-01-04       Impact factor: 12.479

4.  Angiotensin and systems thinking: wrapping your mind around the big picture.

Authors:  Gary Robert Smith
Journal:  Ochsner J       Date:  2013

5.  Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome.

Authors:  Michael W Manning; Mary Cooter; Joseph Mathew; John Alexander; Eric Peterson; T Bruce Ferguson; Renato Lopes; Mihai Podgoreanu
Journal:  Ann Thorac Surg       Date:  2017-01-25       Impact factor: 4.330

Review 6.  The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches.

Authors:  Rachel D Simmons; Sandeep Kumar; Hanjoong Jo
Journal:  Arch Biochem Biophys       Date:  2015-12-11       Impact factor: 4.013

7.  Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse.

Authors:  Hirohisa Kawahata; Daisuke Sotobayashi; Motokuni Aoki; Hideo Shimizu; Hironori Nakagami; Toshio Ogihara; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

8.  New take on the role of angiotensin II in cardiac hypertrophy and fibrosis.

Authors:  Mazen Kurdi; George W Booz
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

9.  Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1.

Authors:  P A Galie; M W Russell; M V Westfall; J P Stegemann
Journal:  Exp Cell Res       Date:  2011-10-14       Impact factor: 3.905

10.  Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

Authors:  Gohei So; Shinsuke Nakagawa; Yoichi Morofuji; Takeshi Hiu; Kentaro Hayashi; Kunihiko Tanaka; Kazuhiko Suyama; Maria A Deli; Izumi Nagata; Takayuki Matsuo; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2014-12-30       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.